只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-28 2026-07-29 | DGX QUEST DIAGNOSTICS INC | DELANEY MARK E Officer · SVP & Chief Commercial Officer | 卖出（S） | 1,600 | US$235.18 | US$376,288.00 | 10,335 | SEC |
| 2026-07-28 2026-07-29 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,204 | US$254.07 | US$305,900.88 | 132,429 | SEC |
| 2026-07-27 2026-07-29 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,010 | US$260.49 | US$263,095.71 | 133,633 | SEC |
| 2026-07-23 2026-07-24 | IMVT Immunovant, Inc. | Girao Tiago Officer · Chief Financial Officer | 卖出（S） | 6,798 | US$38.69 | US$263,014.62 | 240,798 | SEC |
| 2026-07-10 2026-07-13 | BJDX Bluejay Diagnostics, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 34,938 | US$1.40 | US$48,913.20 | 92,055 | SEC |
| 2026-07-09 2026-07-13 | BJDX Bluejay Diagnostics, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 64,047 | US$1.51 | US$96,710.97 | 126,993 | SEC |
| 2026-07-02 2026-07-06 | LH LABCORP HOLDINGS INC. | Vaughn Bryan T Officer · EVP and President, Diagnostics | 卖出（S） | 234 | US$286.19 | US$66,968.46 | 6,745.5702 | SEC |
| 2026-07-01 2026-07-06 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 369 | US$88.60 | US$32,692.96 | 140,822 | SEC |
| 2026-07-01 2026-07-06 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 575 | US$89.75 | US$51,608.84 | 140,247 | SEC |
| 2026-07-01 2026-07-06 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 1,693 | US$90.62 | US$153,422.03 | 138,554 | SEC |
| 2026-07-01 2026-07-06 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 100 | US$267.19 | US$26,718.50 | 137,543 | SEC |
| 2026-07-01 2026-07-06 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 2,600 | US$272.99 | US$709,774.00 | 134,943 | SEC |
| 2026-07-01 2026-07-06 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 300 | US$274.06 | US$82,218.00 | 134,643 | SEC |
| 2026-06-26 2026-06-26 | IMVT Immunovant, Inc. | Girao Tiago Officer · Chief Financial Officer | 卖出（S） | 10,000 | US$38.46 | US$384,600.00 | 247,596 | SEC |
| 2026-06-09 2026-06-10 | BORR Borr Drilling Ltd | Mordehachvili Thiago Director | 卖出（S） | 8,000,000 | US$4.70 | US$3760万 | 38,199,677 | SEC |
| 2026-06-04 2026-06-08 | DGX QUEST DIAGNOSTICS INC | KUPPUSAMY KARTHIK Officer · SVP, Clinical Solutions | 卖出（S） | 8,147 | US$200.00 | US$162.94万 | 13,510 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 76 | US$104.82 | US$7,966.32 | 142,537 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 926 | US$106.11 | US$98,257.86 | 141,611 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 216 | US$107.07 | US$23,127.12 | 141,395 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 244 | US$108.15 | US$26,388.60 | 141,151 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 424 | US$109.18 | US$46,292.32 | 140,727 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 1,386 | US$111.24 | US$154,178.64 | 139,285 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 877 | US$111.94 | US$98,171.38 | 138,408 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 772 | US$113.03 | US$87,259.16 | 137,636 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 28 | US$113.62 | US$3,181.36 | 137,608 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 269 | US$104.03 | US$27,984.07 | 142,613 | SEC |
| 2026-06-01 2026-06-03 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 56 | US$110.52 | US$6,189.12 | 140,671 | SEC |
| 2026-06-01 2026-06-03 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,802 | US$217.52 | US$391,971.04 | 138,841 | SEC |
| 2026-06-01 2026-06-03 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 413 | US$218.84 | US$90,380.92 | 138,428 | SEC |
| 2026-06-01 2026-06-03 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 213 | US$219.34 | US$46,719.42 | 138,215 | SEC |
| 2026-06-01 2026-06-03 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 572 | US$220.67 | US$126,223.24 | 137,643 | SEC |
| 2026-06-01 2026-06-02 | DGX QUEST DIAGNOSTICS INC | Davis J. E. Director,Officer · CEO and President | 卖出（S） | 10,000 | US$194.14 | US$194.14万 | 132,423 | SEC |
| 2026-05-26 2026-05-28 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,652 | US$202.84 | US$335,091.68 | 140,643 | SEC |
| 2026-05-20 2026-05-21 | LUCD Lucid Diagnostics Inc. | Matheis Dennis Director | 买入（P） | 245,000 | US$1.00 | US$245,000.00 | 1,033,443 | SEC |
| 2026-05-19 2026-05-21 | TEM Tempus AI, Inc. | Schoenherr Thomas Edward Officer · CEO, Diagnostics | 卖出（S） | 1,580 | US$44.07 | US$69,630.60 | 107,029 | SEC |
| 2026-05-08 2026-05-12 | TMQ Trilogy Metals Inc. | Hensley William L. Iggiagruk Director | 卖出（S） | 50,000 | US$4.44 | US$222,000.00 | 18,531 | SEC |
| 2026-05-04 2026-05-05 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 3,580 | US$106.70 | US$381,986.00 | 143,850 | SEC |
| 2026-05-04 2026-05-05 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 968 | US$107.35 | US$103,914.80 | 142,882 | SEC |
| 2026-05-04 2026-05-05 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 392 | US$104.78 | US$41,073.76 | 147,764 | SEC |
| 2026-05-04 2026-05-05 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 334 | US$105.13 | US$35,113.42 | 147,430 | SEC |
| 2026-05-01 2026-05-05 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 328 | US$100.71 | US$33,032.88 | 150,471 | SEC |
| 2026-05-01 2026-05-05 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 904 | US$102.68 | US$92,822.72 | 149,483 | SEC |
| 2026-05-01 2026-05-05 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 84 | US$101.87 | US$8,557.08 | 150,387 | SEC |
| 2026-05-01 2026-05-05 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 1,327 | US$103.57 | US$137,437.39 | 148,156 | SEC |
| 2026-05-01 2026-05-05 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 560 | US$200.95 | US$112,532.00 | 144,735 | SEC |
| 2026-05-01 2026-05-05 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 400 | US$205.31 | US$82,124.00 | 142,445 | SEC |
| 2026-05-01 2026-05-05 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 865 | US$204.47 | US$176,866.55 | 142,845 | SEC |
| 2026-05-01 2026-05-05 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 405 | US$206.16 | US$83,494.80 | 145,295 | SEC |
| 2026-05-01 2026-05-05 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 150 | US$206.93 | US$31,039.50 | 142,295 | SEC |
| 2026-05-01 2026-05-05 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 520 | US$201.60 | US$104,832.00 | 144,215 | SEC |
| 2026-05-01 2026-05-05 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 505 | US$203.32 | US$102,676.60 | 143,710 | SEC |
| 2026-04-27 2026-04-29 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 997 | US$203.75 | US$203,138.75 | 146,885 | SEC |
| 2026-04-27 2026-04-29 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,185 | US$204.39 | US$242,202.15 | 145,700 | SEC |
| 2026-04-27 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 250,923 | US$3.64 | US$913,359.72 | 12,684,884 | SEC |
| 2026-04-27 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 250,923 | US$3.64 | US$913,359.72 | 12,684,884 | SEC |
| 2026-04-27 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 250,923 | US$3.64 | US$913,359.72 | 12,684,884 | SEC |
| 2026-04-27 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,684,884 | SEC |
| 2026-04-27 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,684,884 | SEC |
| 2026-04-27 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,684,884 | SEC |
| 2026-04-24 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,433,961 | SEC |
| 2026-04-24 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,433,961 | SEC |
| 2026-04-24 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,433,961 | SEC |
| 2026-04-24 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 38,880 | US$3.53 | US$137,246.40 | 12,433,961 | SEC |
| 2026-04-24 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 38,880 | US$3.53 | US$137,246.40 | 12,433,961 | SEC |
| 2026-04-24 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 38,880 | US$3.53 | US$137,246.40 | 12,433,961 | SEC |
| 2026-04-23 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,395,081 | SEC |
| 2026-04-23 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,395,081 | SEC |
| 2026-04-23 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,395,081 | SEC |
| 2026-04-23 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 280,381 | US$3.50 | US$981,333.50 | 12,395,081 | SEC |
| 2026-04-23 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 280,381 | US$3.50 | US$981,333.50 | 12,395,081 | SEC |
| 2026-04-23 2026-04-27 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 280,381 | US$3.50 | US$981,333.50 | 12,395,081 | SEC |
| 2026-04-23 2026-04-24 | IMVT Immunovant, Inc. | Girao Tiago Officer · Chief Financial Officer | 卖出（S） | 25,760 | US$29.62 | US$763,011.20 | 247,596 | SEC |
| 2026-04-20 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,114,700 | SEC |
| 2026-04-20 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,114,700 | SEC |
| 2026-04-20 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,114,700 | SEC |
| 2026-04-20 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 40,690 | US$3.88 | US$157,877.20 | 12,114,700 | SEC |
| 2026-04-20 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 40,690 | US$3.88 | US$157,877.20 | 12,114,700 | SEC |
| 2026-04-20 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 40,690 | US$3.88 | US$157,877.20 | 12,114,700 | SEC |
| 2026-04-17 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,074,010 | SEC |
| 2026-04-17 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,074,010 | SEC |
| 2026-04-17 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,074,010 | SEC |
| 2026-04-17 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 40,114 | US$3.57 | US$143,206.98 | 12,074,010 | SEC |
| 2026-04-17 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 40,114 | US$3.57 | US$143,206.98 | 12,074,010 | SEC |
| 2026-04-17 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 40,114 | US$3.57 | US$143,206.98 | 12,074,010 | SEC |
| 2026-04-17 2026-04-20 | ATLX Atlas Lithium Corp | Miranda Tiago Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 5,831 | US$5.03 | US$29,329.93 | 30,000 | SEC |
| 2026-04-16 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 102,057 | US$3.45 | US$352,096.65 | 12,033,896 | SEC |
| 2026-04-16 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 102,057 | US$3.45 | US$352,096.65 | 12,033,896 | SEC |
| 2026-04-16 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 102,057 | US$3.45 | US$352,096.65 | 12,033,896 | SEC |
| 2026-04-16 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD CAPITAL INC TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,033,896 | SEC |
| 2026-04-16 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,033,896 | SEC |
| 2026-04-16 2026-04-20 | IMDX Insight Molecular Diagnostics Inc. | Bradsher Neal C TenPercentOwner | 买入（P） | 0 | US$0.00 | US$0.00 | 12,033,896 | SEC |
| 2026-04-16 2026-04-20 | ATLX Atlas Lithium Corp | Miranda Tiago Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 4,400 | US$5.00 | US$22,000.00 | 35,831 | SEC |
| 2026-04-16 2026-04-20 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 1,250 | US$86.55 | US$108,187.50 | 152,192 | SEC |
| 2026-04-16 2026-04-20 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 958 | US$87.81 | US$84,121.98 | 151,234 | SEC |
| 2026-04-16 2026-04-20 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 363 | US$88.25 | US$32,034.75 | 150,871 | SEC |
| 2026-04-16 2026-04-20 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 60 | US$89.41 | US$5,364.60 | 0 | SEC |
| 2026-04-16 2026-04-20 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 1,111 | US$86.59 | US$96,201.49 | 1,277 | SEC |
| 2026-04-16 2026-04-20 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 1,106 | US$87.83 | US$97,139.98 | 171 | SEC |
| 2026-04-16 2026-04-20 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 111 | US$88.38 | US$9,810.18 | 60 | SEC |
| 2026-04-16 2026-04-20 | ZM Zoom Communications, Inc. | Subotovsky Santiago Director | 卖出（S） | 72 | US$89.41 | US$6,437.52 | 150,799 | SEC |
| 2026-04-08 2026-05-19 | REPX Riley Exploration Permian, Inc. | Arriaga Brent Alexander Director | 卖出（S） | 2,500 | US$38.94 | US$97,350.00 | 16,633 | SEC |
| 2026-04-01 2026-04-03 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,000 | US$202.36 | US$202,360.00 | 148,834 | SEC |
| 2026-04-01 2026-04-03 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 952 | US$203.31 | US$193,551.12 | 147,882 | SEC |
| 2026-04-01 2026-04-03 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,048 | US$201.32 | US$210,983.36 | 149,834 | SEC |
| 2026-03-14 2026-05-18 | BJDX Bluejay Diagnostics, Inc. | Dey Svetlana Director | 买入（P） | 12,500 | US$2.00 | US$25,000.00 | 12,501 | SEC |
| 2026-03-14 2026-05-18 | BJDX Bluejay Diagnostics, Inc. | ZEIDMAN FRED S Director | 买入（P） | 12,500 | US$2.00 | US$25,000.00 | 12,500 | SEC |
| 2026-03-14 2026-05-18 | BJDX Bluejay Diagnostics, Inc. | CHASE DONALD R Director | 买入（P） | 12,500 | US$2.00 | US$25,000.00 | 12,525 | SEC |
| 2026-03-14 2026-05-18 | BJDX Bluejay Diagnostics, Inc. | Dey Indranil Director,Officer · President and CEO | 买入（P） | 12,500 | US$2.00 | US$25,000.00 | 12,522 | SEC |
| 2026-03-14 2026-05-18 | BJDX Bluejay Diagnostics, Inc. | Wurth Douglas Clark Director | 买入（P） | 12,500 | US$2.00 | US$25,000.00 | 12,608 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| VIAG | 662 | 0 | 790.197 | 83.78% | Q |
| IAG | 552,267.5998 | 10,312 | 1,258,041.8057 | 43.90% | B, Q, N |
| IAGG | 132,036.9494 | 0 | 458,188.2551 | 28.82% | B, Q, N |